LIMITLESS DIAGNOSTICS LLC
NPI 1548825730
Clinical Medical Laboratory in Jessup, PA
NPI Status: Active since May 03, 2019
Contact Information
1 ALBERIGI DR STE 109
JESSUP, PA
ZIP 18434
Phone: (855) 456-1175
- Organization
- Clinical Medical Laboratory
- CLIA Number: 39D2169186
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 12-20-2026
About LIMITLESS DIAGNOSTICS LLC
This page provides the complete NPI Profile along with additional information for Limitless Diagnostics Llc, a provider established in Jessup, Pennsylvania operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1548825730 assigned on May 2019. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The authorized official of this NPI record is Gregory Agle (Owner)
- NPI
- 1548825730
- Provider Name
- LIMITLESS DIAGNOSTICS LLC
- Entity Type
- Organization
- Location Address
- 1 ALBERIGI DR STE 109 JESSUP, PA 18434
- Location Phone
- (855) 456-1175
- Mailing Address
- 3435 BELMONT TER DAVIE, FL 33328
- Mailing Phone
- (855) 546-1175
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 05-03-2019
- Last Update Date
- 04-01-2022
- Code Navigator
Establishments like Limitless Diagnostics Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants
Gene analysis (adenomatous polyposis coli), full gene sequence
Gene analysis (bloom syndrome, recq helicase-like)
Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants
Gene analysis (coagulation factor ix) full sequence analysis
Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants
Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants
Gene analysis (frataxin) of full sequence
Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis
Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis
Gene analysis (muts homolog 6 [e coli]) full sequence analysis
Gene analysis (partner and localizer of brca2) full sequence analysis
Gene analysis (phosphatase and tensin homolog), full sequence analysis
Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis
Test for detecting genes associated with heart disease, duplication/deletion analysis panel
Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes
Test for detecting genes associated with inherited disease of heart muscle
Gene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.
This service was performed 19 times for 19 patientsGene analysis of the adenomatous polyposis coli (APC) involves studying the entire sequence of the APC gene. This test helps identify mutations that could lead to conditions like familial adenomatous polyposis. The procedure is non-invasive and uses a blood sample.
This service was performed 271 times for 271 patientsGene analysis for Bloom Syndrome involves studying the RECQ helicase-like gene. This gene is responsible for DNA repair. When it's not working properly, it can lead to Bloom Syndrome, a condition that increases the risk of developing various types of cancer.
This service was performed 279 times for 279 patientsGene analysis for breast cancer 1 and 2 involves studying your DNA to detect alterations that may increase your risk of developing certain health issues. This test analyzes the full sequence and checks for duplication or deletion variants.
This service was performed 126 times for 126 patientsGene analysis for coagulation factor IX is a process that examines your genes, specifically the one responsible for factor IX - a protein that helps blood clot. It can detect any changes or mutations in this gene, which could affect your body's ability to control bleeding.
This service was performed 16 times for 16 patientsGene analysis of cytochrome P450 2C19 common variants is a test that helps understand how your body processes certain medications. This can help your doctor tailor treatments specifically for you, improving their effectiveness and safety.
This service was performed 11 times for 11 patientsGene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.
This service was performed 14 times for 14 patientsGene analysis of frataxin involves studying the entire sequence of the frataxin gene. This test helps identify any changes or mutations in the gene that may cause health issues, such as Friedreich's ataxia. It's a non-invasive procedure using a blood sample.
This service was performed 93 times for 93 patientsGene analysis, specifically for MUTL Homolog 1, linked to colon cancer, involves studying your DNA sequence. This helps identify any changes or mutations that might increase your risk of developing colon cancer. It's a preventive measure to manage potential health risks.
This service was performed 44 times for 44 patientsGene analysis (MUTYH) full sequence analysis is a test that examines your DNA to identify any changes linked to nonpolyposis colon cancer type 1. This can help determine your risk of developing this type of cancer.
This service was performed 273 times for 273 patientsGene analysis, specifically MUTS Homolog 6 (E. coli) full sequence analysis, is a test that examines your DNA to identify changes in the MUTS Homolog 6 gene. This information helps doctors understand and manage potential health concerns.
This service was performed 268 times for 268 patientsGene analysis, specifically for the partner and localizer of BRCA2, involves examining your genetic code to identify any changes in this particular gene. This gene is significant in maintaining the health of your cells. The full sequence analysis means we look at every part of this gene to ensure it's working properly.
This service was performed 295 times for 294 patientsGene analysis, specifically phosphatase and tensin homolog (PTEN) full sequence analysis, is a test that looks at your DNA to identify any changes in the PTEN gene. This gene helps control cell growth and division. Changes may lead to certain health conditions.
This service was performed 13 times for 13 patientsGene analysis, specifically postmeiotic segregation increased 2 (s cerevisiae) full sequence analysis, is a scientific procedure. It involves studying your entire genetic code to identify any changes or differences that could be related to certain health conditions. This is done in a lab, using a sample provided by you.
This service was performed 258 times for 258 patientsThis test identifies genetic markers linked to heart disease. The duplication/deletion analysis panel scans your DNA for changes that may increase your risk. Understanding your genetic profile can help manage potential heart health risks.
This service was performed 86 times for 86 patientsThis test analyzes at least 9 specific genes associated with heart disease. It uses a method called genomic sequencing to identify potential genetic risks. Understanding these risks can help in managing heart health more effectively.
This service was performed 88 times for 88 patientsThis test identifies genetic markers linked to inherited heart muscle conditions. It involves a simple blood or saliva sample. The lab analyzes your DNA for specific mutations. Results can help manage potential heart health risks.
This service was performed 89 times for 89 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 39D2169186
- Facility Type
- Independent
- Certificate Effective Date
- December 21, 2024
- Certificate Expiration Date
- December 20, 2026
- Laboratory Director
- DR. JOHN D. HANSON
- Certificate Type
- Certificate of Accreditation
- Certificate Type Description
- This is a CLIA certificate is issued to Limitless Diagnostics Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.
Reviews for LIMITLESS DIAGNOSTICS LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1548825730, we treat the final digit (0) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 70. The final step is to find the difference between that total and the next multiple of ten (70 - 70 = 0).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 70 is 70. The difference is the calculated check digit.
Other Providers at the Same Location
The following 1 provider is registered at the same or a nearby location.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1548825730, enumerated as an "organization" on May 03, 2019.
The provider is located at 1 ALBERIGI DR STE 109 JESSUP, PA 18434 and the phone number is (855) 456-1175.
Clinical Medical Laboratory with taxonomy code 291U00000X.
